| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : Development of a Novel Population Pharmacokinetic (PK)-Based Method to Describe the Time-Course of Gatifloxacin (GAT) Middle Ear Fluid (MEF) Concentrations in Children | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: Christopher M. Rubino
Primary Author: Christopher M. Rubino
Event: ICAAC 2003 Chicago, IL
Sponsor: Bristol-Myers Squibb
Other Contributors: E. Leibovitz (2), B. Cirincione (1), L. Phillips (1), B. Damle (3), R. Dagan (2), J. Blumer (4), D. Grasela (3)
(1) Cognigen Corporation, Buffalo, NY; (2) Soroka University Medical Center, Beer-Sheva, Israel; (3) Bristol-Myers Squibb, Princeton, NJ; (4) Rainbow Babies and Children's Hospital PPRU, Cleveland, OH
Reprints currently not available.
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : ICAAC 2003 : Development of a Novel Population Pharmacokinetic (PK)-Based Method to Describe the Time-Course of Gatifloxacin (GAT) Middle Ear Fluid (MEF) Concentrations in Children | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |